Koninklijke Philips (NYSE:PHG) Short Interest Update

Koninklijke Philips (NYSE:PHG - Get Free Report) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 2,360,000 shares, an increase of 18.0% from the February 13th total of 2,000,000 shares. Currently, 0.3% of the company's stock are short sold. Based on an average trading volume of 723,000 shares, the days-to-cover ratio is currently 3.3 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Colonial Trust Co SC raised its stake in Koninklijke Philips by 724.0% during the fourth quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company's stock valued at $36,000 after purchasing an additional 1,238 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Koninklijke Philips in the 3rd quarter worth $54,000. Farther Finance Advisors LLC increased its holdings in shares of Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company's stock worth $54,000 after buying an additional 582 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in shares of Koninklijke Philips during the 4th quarter valued at about $55,000. Finally, Millstone Evans Group LLC bought a new position in shares of Koninklijke Philips in the 4th quarter valued at about $60,000. 13.67% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on PHG shares. StockNews.com raised shares of Koninklijke Philips from a "hold" rating to a "buy" rating in a research report on Saturday, March 8th. Sanford C. Bernstein upgraded shares of Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. UBS Group upgraded shares of Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday, February 20th. Finally, BNP Paribas raised Koninklijke Philips from a "neutral" rating to an "outperform" rating in a report on Tuesday, February 25th. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy".

Remove Ads

Koninklijke Philips Price Performance

Shares of NYSE:PHG traded down $0.35 during trading on Friday, hitting $25.53. 720,804 shares of the company's stock were exchanged, compared to its average volume of 869,719. The company has a market cap of $24.00 billion, a price-to-earnings ratio of -30.39, a PEG ratio of 0.82 and a beta of 0.78. The business's 50-day simple moving average is $26.73 and its 200 day simple moving average is $27.72. Koninklijke Philips has a 52-week low of $19.10 and a 52-week high of $32.91. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.10 billion. As a group, equities analysts predict that Koninklijke Philips will post 1.63 EPS for the current year.

Koninklijke Philips Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips's payout ratio is -89.29%.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.